Gold tier: mechanically validated evidence, with its primary source.
369 evidence items · page 2 / 15
7.3 %Among HIV-infected pregnant women exposed to nevirapine (NVP) during the first trimester, the proportion of abortion was 7.3%.
Côte d'IvoireVIH/sidaobserved 2003–2009published 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0b013e3181ff04e6
10.9 %10.9% of patients were lost to follow-up during antiretroviral chemoprophylaxis.
Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations
17 participantsSeventeen participants had plasma HIV-2 RNA of 50 copies per mL or greater at least once.
Côte d'IvoireVIH/sidapublished 2024The lancet. HIVeurope_pmcdocument of 7 observations
10.2 %Of 551 HIV-2 patients on ART, 10.2% were lost to follow-up during the median time on ART of 2.4 years.
Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations
29 casesAmong the 128 cases of non-occupational HIV exposure, 29 were due to condom rupture.
Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations
10 %Among hospitalized HIV-positive adults in West Africa who died, cerebral toxoplasmosis was a fatal disease in 10% of deaths.
Côte d'Ivoirecerebral toxoplasmosis · VIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797
1.01 aOR_per_50_cells_per_mm3An increase in CD4 cell count between M0 and M24 was associated with being overweight or obese (adjusted odds ratio 1.01 per +50 cells/mm³, 95% confidence interval 1.05–1.13, p = 0.01).
Côte d'IvoireVIH/sidapublished 2016AIDS research and therapyeurope_pmcdocument of 9 observations
75.2 %Among 161 antiretroviral-naïve HIV-HBV coinfected patients in Côte d'Ivoire, 121 (75.2%) had detectable HBV DNA.
Côte d'Ivoirehépatite B · VIH/sidapublished 2016Journal of gastroenterology and hepatologyeurope_pmcdocument of 11 observationsDOI 10.1111/jgh.13156
23 %Among ART-naive HIV-1-infected adults in Côte d'Ivoire, 23% had never been exposed to HBV.
Côte d'Ivoirehépatite B · VIH/sidapublished 2010Antiviral therapyeurope_pmcdocument of 7 observations
9.7 %Three (9.7%) HIV-2 patients switched to an integrase inhibitor-based regimen.
Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642
25.7 %Among 1825 HIV-2-infected individuals initiating antiretroviral therapy, 469 (25.7%) were lost to follow-up over the first 24 months.
Côte d'IvoireVIH/sidapublished 2016AIDS (London, England)europe_pmcdocument of 6 observations
5.9 %At month 36, 5.9% of the patients had died.
Côte d'IvoireVIH/sidapublished 2018HIV/AIDS (Auckland, N.Z.)europe_pmcdocument of 7 observations
465 cells/mm3Patients in the immediate group had a median CD4 count of 465 cells/mm3 at baseline.
Côte d'IvoireVIH/sidapublished 2021The Journal of antimicrobial chemotherapyeurope_pmcdocument of 8 observations
45 %Plasma HIV-1 RNA load was elevated (≥ 5 log₁₀ copies/mL) in 45% of 491 patients.
Côte d'IvoireVIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations
48 patients48 patients (77.4%) were undergoing chemoprophylaxis with cotrimoxazole.
Côte d'IvoireVIH/sidaobserved 1999–2006published 2010Le Mali medicaleurope_pmcdocument of 17 observations
73 %The survival analysis showed a probability of remaining alive and in care of 73.0% after 72 months.
Côte d'IvoireVIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations
45 yearsThe median age of HIV-2-infected individuals initiating antiretroviral therapy was 45 years.
Côte d'IvoireVIH/sidapublished 2016AIDS (London, England)europe_pmcdocument of 6 observations
3 %Dual-type HIV (type 1 plus type 2) was found in 3% of 491 adult HIV patients.
Côte d'IvoireVIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations
80.7 %The survival analysis showed a probability of remaining alive and in care of 80.7% after 48 months.
Côte d'IvoireVIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations
42 %Among ART-naive HIV-1-infected adults in Côte d'Ivoire, 42% had isolated anti-HBc.
Côte d'Ivoirehépatite B · VIH/sidapublished 2010Antiviral therapyeurope_pmcdocument of 7 observations
7 %At month 6, 7% of HIV-1-infected adults on zidovudine + lamivudine + efavirenz had abnormal transaminase value.
Côte d'IvoireVIH/sidaobserved month 6published 2006Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/01.qai.0000219777.04927.50
1.7 per_100_person_yearsIn patients with pre-ART CD4 cell count 200–349 cells/μL, incidence of mortality was 1.7 per 100 person-years.
Côte d'IvoireVIH/sidapublished 2007AIDS (London, England)europe_pmcdocument of 9 observations
85.7 %Of the 312 patients initially classified as HIV-2, 267 (85.7%) were confirmed as HIV-2.
Côte d'IvoireVIH/sidaobserved 2012published 2014Journal of the International AIDS Societyeurope_pmcdocument of 8 observations
100,000 copies/mLBaseline HIV-1 RNA <100 000 copies/mL was associated with virologic success.
Côte d'IvoireVIH/sidaobserved baselinepublished 2022Open Forum Infectious Diseaseseurope_pmcdocument of 4 observationsDOI 10.1093/ofid/ofac628
30 deathsIn the Temprano ANRS 12136 trial posttrial phase, 30 deaths occurred among HIV-infected West African adults who were randomized to defer antiretroviral therapy.
Côte d'IvoireVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 6 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.